Memantine
- Product NDC
- 72603-118
- 11-digit product format
- 726030118
- Labeler code
- 72603
- Product ID
- 72603-118_dd10c9a1-a7af-b51f-4317-ee2290f19a85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Memantine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA090048
- Marketing category
- ANDA
- Marketing start
- 2022-09-13
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Memantine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEMANTINE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JY0WD0UA60 |
| Rxcui | 996561, 996571 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-118-01 | Memantine | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-118 | MEMANTINE TABLET [NORTHSTAR RXLLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20231227_7a40ed9d-8853-b616-ff47-0c7b0fd28959.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72603-118-01 | 72603011801 | 60 TABLET in 1 BOTTLE (72603-118-01) | 60 tablet | 2022-09-13 | 0000-00-00 | No | No | Current |